Conceptio › Archive › NCBI PubMed Central
NCBI PubMed Centralopen access

Efficacy and Safety of Envafolimab Combined With Capecitabine and Lenvatinib as Postoperative Adjuvant Therapy in Resected Biliary Tract Cancer With High-Risk Recurrence Factors: A Phase II Single-Center Prospective Study.

Tian Y et al.
NCBI PubMed Central · Papers · License: Open Access
Open Source ↗Direct PDF ↓
machine learning systems
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 156944
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.